Varian's Halcyon receives Brazilian market clearance
Varian Medical Systems' Halcyon radiation therapy system has received clearance...Read more on AuntMinnie.comRelated Reading: Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil Varian secures Japanese clearance for Halcyon Varian names new chief people officer Varian's fiscal 2017 results hold steady
ConclusionmiR-21/146a/155 might be useful potential factors of radiosensitivity and acute genitourinary radiotoxicity in prostate cancer patients. miRNA might have great potential as predictors of various pathological conditions extracted from PBMCs.
Background Partial breast reconstruction with reduction mammaplasty is an accepted option for women with breast cancer who wish to receive breast conserving therapy. With additional surgery and potential postoperative complications, the impact this approach has on the timely initiation of adjuvant radiation therapy has been raised as a concern. The purpose of this study was to determine if any postoperative complications after oncoplastic reduction (OCR) are associated with a delay in time to radiation. Methods All patients undergoing OCR with postoperative adjuvant radiation at a single institution between 1997 and 2...
We present a rare case of a patient who developed Raynaud phenomenon of the lower face and tongue in the presence of spasmodic torticollis after mandibulectomy and free fibula reconstruction followed by RT to the oral cavity and neck. Possible causes, pathophysiologic mechanisms and treatment options are discussed. This is the first report of botulinum toxin treatment of isolated secondary Raynaud phenomenon of the lower face and tongue.
Conclusions The current study demonstrates the safety of both pedicled and free flap reconstruction in previously irradiated sarcoma defects. Judicious selection of reconstructive technique and recipient vessels is crucial in obtaining optimal outcomes given the devastating effects of RT on native tissues.
Conclusions In an animal model of irradiated tissue expander–based breast reconstruction, treatment with topical DFX improved the cutaneous vascularity and tissue pliability, resulting in vascular density and final tissue expansion volumes similar to those found in the nonirradiated control group. Topical DFX may be an effective agent for the treatment of soft tissue radiation injury; future studies are indicated to further characterize this novel drug formulation.
Radiation therapy software developer RaySearch Laboratories said it will develop...Read more on AuntMinnie.comRelated Reading: RaySearch to unveil new deep-learning software at ASTRO RaySearch signs Canadian cancer center RaySearch, Canon sign collaboration pact RaySearch signs Swedish Cancer Institute RaySearch to highlight software upgrades at AAPM
Conclusions: IMRT provided improved dose coverage than conventional radiotherapy. However, IMRT failed to lower patients' risks for skin toxicity and may have the potential to increase skin toxicity.
ConclusionsInvolvement of the PSW should not prevent obtaining R0 resection. Although the LEPR is associated with considerable morbidity ( ≈ 30%), a long-term survival seems to be achieved in those women with complete resection.
ConclusionsGynecologic cancer radiotherapy patients want to discuss sexual health, but report suboptimal provider inquiry. Patient views and experiences varied based on marital status, education level, and FSFI score. This work highlights the need for improved sexual health communication between cancer patients and providers.
ConclusionsAn SBRT boost dose of 30 Gy can be delivered without compromising QUANTEC OAR limits. The use of SBRT increases TCP values, regardless of the input parameters.